ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

August 26, 2005

NCI Approved CTEP Trials For the Month of August

August 31, 2012

Flat NIH Budget Threatens Future Of Research, Universities Say.

March 14, 2008

U.S., Canada To Collaborate On Indian Health Services.

May 17, 2002

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002

Did ACS Flip-Flop On Stem Cell Research? Society Says No, Patient Coalition Says Yes

September 10, 1999